Annals of Human Biology (Nov 2022)

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population

  • Tamara Božina,
  • Lana Ganoci,
  • Ena Karačić,
  • Livija Šimičević,
  • Majda Vrkić-Kirhmajer,
  • Iva Klarica-Domjanović,
  • Tena Križ,
  • Zrinka Sertić,
  • Nada Božina

DOI
https://doi.org/10.1080/03014460.2022.2140826
Journal volume & issue
Vol. 49, no. 7-8
pp. 323 – 331

Abstract

Read online

Background Organic anion-transporting polypeptide 1B1 (OATP1B1) and the ATP-binding cassette subfamily G member 2, ABCG2, are important transporters involved in the transport of endogenous substrates and xenobiotics, including drugs. Genetic polymorphisms of these transporters have effect on transporter activity. There is significant interethnic variability in the frequency of allele variants. Aim To determined allele and genotype frequencies of ABCG2 and SLCO1B1 genes in Croatian populations of European descent. Subjects and methods A total of 905 subjects (482 women) were included. Genotyping for ABCG2 c.421C > A (rs2231142) and for SLCO1B1 c.521T > C (rs4149056), was performed by real-time polymerase chain reaction (PCR) using TaqMan® DME Genotyping Assays. Results For ABCG2 c.421C > A, the frequency of CC, CA and AA genotypes was 81.4%, 17.8% and 0.8% respectively. The frequency of variant ABCG2 421 A allele was 9.7%. For SLCO1B1 c.521T > C, the frequency of TT, TC and CC genotypes was 61.7%, 34.8% and 3.5% respectively. The frequency of variant SLCO1B1 521 C allele was 20.9%. Conclusion The frequency of the ABCG2 and SLCO1B1 allelic variants and genotypes in the Croatian population is in accordance with other European populations. Pharmacogenetic analysis can serve to individualise drug therapy and minimise the risk of developing adverse drug reactions.

Keywords